DNA damage repair in ovarian cancer: unlocking the heterogeneity

Abstract Treatment for advanced ovarian cancer is rarely curative; three quarters of patients with advanced disease relapse and ultimately die with resistant disease. Improving patient outcomes will require the introduction of new treatments and better patient selection. Abrogations in the DNA damag...

Full description

Bibliographic Details
Main Authors: Mary Ellen Gee, Zahra Faraahi, Aiste McCormick, Richard J. Edmondson
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Journal of Ovarian Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13048-018-0424-x